Redpoint Investment Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-7,510
Closed -$249K 609
2022
Q2
$249K Buy
7,510
+1,314
+21% +$55.8K 0.03% 552
2022
Q1
$447K Buy
+6,196
New +$446K 0.04% 445
2021
Q1
Sell
-3,213
Closed -$642K 667
2020
Q4
$642K Buy
3,213
+1,485
+86% +$302K 0.07% 310
2020
Q3
$379K Buy
1,728
+341
+25% +$72.2K 0.04% 422
2020
Q2
$265K Buy
+1,387
New +$243K 0.01% 515

Other funds holding TDOC

Redpoint Investment Management's TDOC Position: Q3 2022 in Review

Redpoint Investment Management sold out of Teladoc Health (TDOC) in Q3 2022, closing a stake of 7,510 shares — an estimated $249K sold.

Redpoint Investment Management first reported a position in TDOC in Q2 2020 and held it in 5 quarters. The position peaked at $642K in Q4 2020. 482 funds tracked by Wall St. Rank hold TDOC as of Q3 2022.

  • Redpoint Investment Management reported no remaining Teladoc Health position as of Q3 2022 after selling out during the quarter.
  • Redpoint Investment Management sold 7,510 Teladoc Health shares in Q3 2022, an estimated $249K.
  • Redpoint Investment Management first reported a position in Teladoc Health in Q2 2020 and held it in 5 quarters.
  • Redpoint Investment Management's Teladoc Health position peaked at $642K in Q4 2020.
  • 482 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2022.

Based on Redpoint Investment Management's 13F filing for Q3 2022, filed 14 Oct 2022.